STONY BROOK, N.Y. April 10, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or “the Company”) will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19.“This comprehensive supply chain certification solution allows manufacturers and brands to implement a secure tag, test and track capability into existing production lines quickly,” said Janice Meraglia, Vice President of Government and Military Programs at Applied DNA. “We are looking forward to demonstrating this comprehensive supply chain certification solution at INTERPHEX to pharmaceutical, biotech and medical device companies along with our partner, Videojet.”Applied DNA’s security platform allows companies to tag, test and track a unique molecular tag applied to products or packaging during the manufacturing process. It provides a supply chain management tool to proactively track items globally, adding another level of protection against counterfeits and diversion, transforming the inkjet code into a comprehensive supply chain certification solution. The platform compliments a range of consumer, corporate and government initiatives:

• Communication of covert code information directly from customer to brand owner
• Serialization being implemented by global pharmaceutical companies
• Authentication for counterfeit avoidance under review by government agencies

SigNature® molecular ink, delivered with a Videojet 1860M printer, is created with the addition of a unique, secure molecular tag and is qualified in both black (V4221M) and invisible (V4259M) which can fluoresce blue under UV.The molecular tags facilitate traceability of products and packaging, enabling such claims as the forensic certification of origin, authenticity, provenance, quality, ethics, integrity, or sustainability. The print platform features black and clear inks to meet various application needs associated with supply chain management and brand protection. In addition to pharmaceuticals, biopharma and medical devices, the solution crosses other industries such as food and beverage, aero defense/industrial parts and others.Representatives from Applied DNA and Videojet will be conducting demonstrations at Booth 3957 during the show. For more information, please visit https://adnasprod.wpengine.com/inkjet-codes-molecular-traceability/ and http://www.videojet.com/us/homepage/products/inks-and-ribbons/molecular-cij-inks.html.

Key Features:

Continuous Inkjet (CIJ):

• High-speed, non-contact printing
• Variable alphanumeric coding capabilities

V4221M:

• Black CIJ ink optimized for industrial applications

V4259M:

• Invisible CIJ ink that fluoresces blue under ultraviolet light, ideal for covert applications

Videojet 1860M Printer:

• Provides advanced warning of clogging and extra high tension (EHT) trips
• SIMPLICiTY™ interface greatly reduces operator interactions
• Includes industry-first predictive ink build-up sensor and innovative nozzle system
• Optional VideojetConnect™ Remote Service minimizes the need for on-site service calls

About INTERPHEX
For 39 years, INTERPHEX has proven to be the place to find all of the state-of-the-art solutions you need to cost-effectively develop and manufacture quality product. INTERPHEX is the premier pharmaceutical, biotechnology and device development and manufacturing event where you can “Experience Science through Commercialization.” Based in New York, INTERPHEX brings over 11,000 global industry professionals and 650+ leading suppliers together to “Learn It, Experience It, Procure It” through a combination of no-cost technical conference, exhibits, demonstrations and networking events to leverage quality, efficiency and cost-effectiveness in today’s ever-changing global market.

About Videojet Technologies
Videojet Technologies is a world-leader in the product identification market, providing in-line printing, coding, and marking products, application specific fluids, and product life cycle services. Our goal is to partner with our customers in the consumer packaged goods, pharmaceutical, and industrial goods industries to improve their productivity, to help protect and grow their brands, and to stay ahead of industry trends and regulations. With our customer application experts and technology leadership in continuous inkjet (CIJ), thermal inkjet (TIJ), laser marking, thermal transfer overprinting (TTO), case coding and labeling, and wide array printing, Videojet has more than 345,000 printers installed worldwide. Our customers rely on Videojet products to print on over ten billion products daily. Customer sales, application, service, and training support is provided by direct operations with over 4,000 team members in 26 countries worldwide. In addition, the Videojet distribution network includes more than 400 distributors and OEMs, serving 135 countries.

About Applied DNA
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Applied DNA Sciences has signed an agreement with Colorcon for the use of Applied DNA’s SigNature molecular tags in Colorcon’s product offerings and access to the Company’s associated authentication technologies. These Agreements follow the memorandum of understanding (MOU) announced on December 18, 2017.

Colorcon has teamed up with Applied DNA Sciences to use its DNA tags in pharmaceutical oral dosage formulations, firming up an option it took on the technology last year.

Under the terms of the deal, Colorcon has taken an exclusive license to use APDN’s DNA markers and authentication technologies in film coatings for tablets, as well as a non-exclusive license for their use in inks and colorants. Shares in APDN were up more than 10% after the deal was announced.

By GREGORY ZELLER // APRIL 5, 2018

Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid.

So, Stony Brook-based Applied DNA Sciences should be very happy to receive the first of two “milestone payments” accompanying the March 31 signing of a new licensing deal with Pennsylvania manufacturer Colorcon Inc.

Effective March 31, 2018, Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.

Applied DNA will supply materials to its partner in exchange for long-term royalties based on sales. “Molecular tags will provide traceability for audits and law enforcement and, perhaps most importantly, forensic confirmation of the authenticity of the drug product to the patient and all those in the supply chain, including the pharmacist, the drug distributors and manufacturers,” said James Hayward, President and CEO of Applied DNA, said in a press release issued on April 5, 2018.

Includes Milestone Payments. Long-Term Licensing Royalties to be Paid to Applied DNA Following Sales.

STONY BROOK, N.Y., April 5, 2018 – Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied DNA” or the “Company,”) has signed a License and Cooperation Agreement and a related Supply Agreement (collectively known as the “Agreements”), effective March 31, 2018, with Colorcon, Inc. (“Colorcon”) for the use of Applied DNA’s SigNature® molecular tags in Colorcon’s product offerings and access to the Company’s associated authentication technologies. These Agreements follow the memorandum of understanding (MOU) announced on December 18, 2017.

Under the terms of the Agreements, Applied DNA grants Colorcon exclusive worldwide right to use the Company’s molecular tags and associated authentication technologies in film coatings for solid oral dosage form (“SOD”) applications, for which Colorcon is the largest global supplier, and non-exclusive rights to use the Company’s technologies in inks and colorants for SOD applications. Pursuant to the Agreements, Applied DNA will supply taggant and authentication materials to Colorcon in exchange for long-term royalties on the sale of Colorcon products incorporating the Company’s molecular tags and on the sale of authentication services related thereto. Further, the first of two milestone payments is payable to Applied DNA with the signing of the Agreements. The Company will receive the second milestone payment upon initial approval by a regulatory authority for application in a SOD pharmaceutical or nutraceutical product application. The Agreements generally expire on the later of October 1, 2032 or the last expiration date of any patent licensed pursuant to the Agreements.

“With the signing of these definitive agreements and Colorcon’s industry-leading role, we demonstrate our continuing ability to monetize our DNA molecular taggant platform and associated services to drive revenue growth. The seamless solution integrating our molecular tag with Colorcon’s film coatings puts us on a path to adoption by Colorcon’s current and prospective pharmaceutical customers,” stated Dr. James Hayward, President and CEO of Applied DNA. Dr. Hayward added that: “Molecular tags will provide traceability for audits and law enforcement and, perhaps most importantly, forensic confirmation of the authenticity of the drug product to the patient and all those in the supply chain, including the pharmacist, the drug distributors and manufacturers. We are gratified to be working with a world leader whose sales channel greatly amplifies our combined access to the market.”

“Our teams are already actively engaged in discussions with potential customers,” stated Kelly Boyer, General Manager Film Coatings Business Unit for Colorcon, Inc.

Ms. Boyer continued, “Colorcon has an established reputation for innovation and service. Applied DNA’s SigNature molecular tags and authentication technologies provide value-addition at a time when regulators are demanding that the industry implement serialization in order to track packaging. The collaboration goes a significant step further by enabling traceability at the level of single unit, solid oral doses, and it is complementary to the provisions of the Drug Supply Chain Security Act.”

Colorcon has team members with extensive experience in global regulatory compliance, while Applied DNA has the benefit of several of its management team with experience in the pharmaceutical industry, and the Company has already scaled to supply large, global commercial ecosystems. Applied DNA’s Molecular Tags have been included in over 200 million pounds of cotton, over 15 million pounds of synthetic fibers, and over 800,000 microcircuits for the Department of Defense. The Company’s data portals, supporting hundreds of thousands of data transactions per day, have stored over 300,000 sample testing reports, and are now exchanging data with multiple third-party platforms.

About Colorcon
Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Colorcon’s best-in-class products and technologies are complemented by Colorcon’s extensive application data and value-added services to support all phases of solid oral dose design and development.  Colorcon’s focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice.  That reputation is based on the superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
media contact: Cheryl Schneider, Dian Griesel Int’l, 212-825-3210, cschneider@dgicomm.com
program contact: James A. Hayward, Chief Executive Officer, 631-240-8800, james.hayward@adnas.com
web: www.adnas.com | www.colorcon.com
twitter: @APDN

There’s been a lot of talk in the industry over the last few years about the new consumer, how they’re no longer brand loyal and they only care about landing a deal. And while it’s true that it is more challenging to grab shoppers’ attention today—let alone convince them to pry their wallets open a bit more—it’s not impossible. In fact, there’s plenty of evidence that shows consumers will spend when companies deliver on their brand promises. Not only that, they’ll also become a brand’s best friend, eagerly spreading the word within their friend circles and their social followings.

But too often brands are careless with these hard-fought-for advocates. By offering inferior products and inflating claims, they turn them into disillusioned naysayers, undoing all the effort it took to win them over in the first place.

“It’s all about the trust, and the promises that a brand makes are sacred,” said MeiLin Wan, vice president, textile sales at Applied DNA Sciences. “The investment in goodwill and trust with your customer takes years to develop, but one wrong turn can destroy that trust in a minute especially with the speed of information and all the unknown paths it can take.”

Applied DNA Sciences Inc. has announced that it has fulfilled an order for its molecular tags to track fertilizer delivered by Rosier S.A. to Turkey and a number of African nations.

Applied DNA claims that this initial commercial order follows the successful pilots that were carried out in 2017, in which tagged fertilizer was tracked throughout a supply chain in Africa, and successfully authenticated in the field in front of government officials, agricultural industry players and institutional bankers.

New Order Helps Applied DNA to Secure International Fertilizer Supply Chains

STONY BROOK, N.Y. and MOUSTIER, BE.  March 23, 2018 – Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied DNA” or “the Company,” NASDAQ: APDN), announced that it has fulfilled an order for the Company’s SigNature_^® molecular tags to track granular fertilizer destined for delivery by Rosier S.A. to Turkey and several African countries. This initial commercial order follows last year’s successful pilots, where tagged fertilizer was tracked throughout a supply chain in Africa, and successfully authenticated in the field in front of government officials, agricultural industry players and institutional bankers.

Applied DNA’s SigNify^® in-field testing system is used at the factory to test the tagged fertilizer for outbound quality control. The same system can be used at any point in the supply chain for authentication, without the need for formal laboratory analysis.

Dr. James Hayward, president and CEO of Applied DNA stated, “This initial order is the latest demonstration of our continuing ability to monetize our deep DNA expertise in securing global supply chains to drive top-line growth. The mitigation of fertilizer dilution is a pervasive, global imperative, to which we believe we have the right solution and the right partner in Rosier to address.”

“Rosier plans to lead the fertilizer industry by providing innovative technology giving environmental, economic and social benefits to our various stakeholders. We believe utilizing SigNature DNA is a key step forward in securing supply chains in the regions where we conduct business,” commented Mark Schulz, Business Manager, Rosier Group.

Willy Raymaekers, CEO Rosier Group, adds “Applying DNA to our fertilizers is an excellent and very practical example of Borealis and Rosier high ethical standards. Applying this technology to our fertilizers gives ‘smart fertilization’ a new and important meaning.”

“With the ongoing adulteration of fertilizer, the benefits of molecular tagging for fertilizer manufacturers and farmers are obvious. Products are delivered without the risk of dilution, and the resulting lower crop yields and risks of local malnutrition. More importantly, the opportunity to divert high nitrates to explosive devices is greatly curtailed. Beyond the immediate beneficiaries, there are additional stakeholders that can also benefit from tagged fertilizer, including those governments who may expect a positive impact on GDP ensuring any subsidies to farmers for fertilizer have the desired impact and Banks who provide loans to farmers for the purchase of fertilizers,” stated Tony Benson, Managing Director of Applied DNA for EMEA.

Dr. Hayward continued: “Having just returned from a visit with users and potential users of our technologies throughout Turkey, I am humbled to have seen, firsthand, the potential benefits of our technologies to the farmers, their families, the agricultural industry and to the safety of the Turkish people. We have filed U.S. and international patent applications addressing our proprietary methods to tag, test and track fertilizer products, prevent fertilizer diversion, to quantify fertilizer dilution, and even to recover fertilizer DNA-tags from the environment after fertilizer application, whether the tagged fertilizer was applied to enhance crop yields or to disrupt society.”

In addition to its engagement with Rosier in Turkey, Applied DNA’s SigNature^® DNA is used within textile supply chains, with a significant quantity of American cotton returning to US retailers from Turkish manufacturers, who are known for their superb textile manufacturing skills.

About Rosier SA
Rosier produces and sells high quality mineral fertilizers in Europe, through its exclusive distributor Borealis LAT, and outside Europe to serve its customers in the most reliable way.  We provide farmers with suitable fertilizers considering individual crop and soil conditions. Embedded in the Base Chemicals business of Borealis, our aim is to strengthen our position in selected markets worldwide. With a highly motivated and professional team, we are close to our customers in agriculture. Our backward and forward integration result in supply security as well as high product and service standards.

Thanks to perfectly adapted and state-of-the-art industrial facilities, Rosier is able to offer environmentally friendly products that provide users with the best economical yield they can get. The ROSAFERT^® range primarily comprises simple and compound PK and NPK granulated fertilizers; Specialty fertilisers from the ROSALIQ^® and ROSASOL^® ranges are essentially designed for the greenhouse, foliar complementary nutrition or fertirrigation markets.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT^®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature^®T and fiberTyping^®, targeted towards textiles and apparel, BackTrac^® and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
media contact: Cheryl Schneider, Dian Griesel Int’l, 212-825-3210, cschneider@dgicomm.com
program contact: Tony Benson, Managing Director, Applied DNA Europe, 44 (0) 7552 429341 tony.benson@adnas.com
web: www.adnas.com | www.borealisgroup.com | www.rosier.eu
twitter: @APDN